Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine in Parkinson's disease
Saad Latif, Muhammad Jahangeer, Dure Maknoon Razia, et al.
Clinica Chimica Acta (2021) Vol. 522, pp. 114-126
Closed Access | Times Cited: 215

Showing 1-25 of 215 citing articles:

Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 69
Distinct neurochemical influences on fMRI response polarity in the striatum
Domenic H. Cerri, Daniel L. Albaugh, Lindsay R. Walton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
Shinichi Takahashi, Kyoko Mashima
Antioxidants (2022) Vol. 11, Iss. 1, pp. 170-170
Open Access | Times Cited: 41
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 37
Brain‐derived extracellular vesicles: Potential diagnostic biomarkers for central nervous system diseases
Xiao Xu, Zoya Iqbal, Limei Xu, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 78, Iss. 2, pp. 83-96
Closed Access | Times Cited: 26
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
Ping Chen, Xiaofei Geng
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 23
Overview of Movement Disorders Secondary to Drugs
Jamir Pitton Rissardo, Nilofar Murtaza Vora, Bejoi Mathew, et al.
Clinics and Practice (2023) Vol. 13, Iss. 4, pp. 959-976
Open Access | Times Cited: 22
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
The High-Precision Liquid Chromatography with Electrochemical Detection (HPLC-ECD) for Monoamines Neurotransmitters and Their Metabolites: A Review
Bruno P. Guiard, Guillaume Gotti
Molecules (2024) Vol. 29, Iss. 2, pp. 496-496
Open Access | Times Cited: 11
The Misfolding Mystery: α-syn and the Pathogenesis of Parkinson's Disease
Samir Negi, Navneet Khurana, Navneet Duggal
Neurochemistry International (2024) Vol. 177, pp. 105760-105760
Closed Access | Times Cited: 10
The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
Samira Hassani, Abolghasem Esmaeili
Ageing Research Reviews (2024) Vol. 97, pp. 102299-102299
Closed Access | Times Cited: 9
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Spark-Discharge-Activated 3D-Printed Electrochemical Sensors
Juan F. Hernández-Rodríguez, Maria G. Trachioti, Jan Hrbáč, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 25, pp. 10127-10133
Open Access | Times Cited: 8
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview
Wolf‐Dieter Rausch, Feixue Wang, Khaled Radad
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 487-495
Open Access | Times Cited: 34
Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development
Rita Marques, Rafaela Lacerda, Luı́sa Romão
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1865-1865
Open Access | Times Cited: 32
Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 21
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 21
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
Honglu Yu, Min Xiong, Zhentao Zhang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 20
Developmental Neurotoxicity of Difenoconazole in Zebrafish Embryos
Qing Yang, Ping Deng, Dan Xing, et al.
Toxics (2023) Vol. 11, Iss. 4, pp. 353-353
Open Access | Times Cited: 18
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
Fatemeh Taghizadeh Ghassab, Fatemeh Shamlou Mahmoudi, Reyhaneh Taheri Tinjani, et al.
Life Sciences (2024) Vol. 350, pp. 122748-122748
Closed Access | Times Cited: 7
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
Multi-detection of seratonin and dopamine based on an electrochemical aptasensor
Sare Nur Çuhadar, Habibe Durmaz, Nimet Yildirim-Tirgil
Chemical Papers (2024) Vol. 78, Iss. 12, pp. 7175-7185
Closed Access | Times Cited: 6
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease
Ling Yi, Eng King Tan, Zhidong Zhou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4643-4643
Open Access | Times Cited: 5
Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease
Weixiao Huang, Tao Zhang, Xiaodi Li, et al.
Neuroscience (2024) Vol. 549, pp. 1-12
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top